Le Lézard
Classified in: Health, Business
Subject: PDT

Medicare Supplement Agents: Oxford Life Makes Underwriting Easy with InstaWrite


PHOENIX, Nov. 20, 2019 /PRNewswire/ -- Medicare supplement agents now have an expedited way to assist their clients during the current annual enrollment period.

Medicare Supplement Agents: Oxford Life Makes Underwriting Easy with InstaWrite

Oxford Life® Insurance Company's simple and efficient InstaWriteSM process is now available for the underwriting of Medicare supplement policies. This feature eliminates the interview step that was previously required for these sales.

InstaWrite is a better experience for agents and clients, improving upon the traditional Medicare supplement sales process by offering an almost instant health assessment.

"We have taken an interview process that typically lasts 15 to 20 minutes, and cut it down to about 15 seconds," stated Mike Quaranta, Oxford Life Insurance Company's Vice President of Sales.

Since InstaWrite is an electronic process, agents can perform the underwriting on a laptop computer, tablet or smartphone from a client's residence without involving anyone else.

Simply click on www.oxfordlife.com to sign in as an agent, access the "tools" tab and use the InstaWrite feature.

"The annual enrollment process is Oct. 15 to Dec. 7," Quaranta noted. "It's the period when independent agents conduct their annual reviews with their Medicare clients, and when most Medicare supplement sales are made. InstaWrite enables the qualification process time to be reduced drastically. By addressing the underwriting side of things, the agent's job is streamlined. The time savings is a huge benefit."

Oxford Life introduced InstaWrite in 2018 to streamline the life insurance qualification process. Agents have since embraced the feature to rave reviews.

Call (866) 641-9999 from 5 a.m. to 5 p.m. Monday-Friday for additional details. A  Medicare supplement quick guide is available for download at www.oxfordlife.com.

New Partners
Oxford Life is pleased to announce that it has partnered with two new companies to offer Individual Vision® and ChooseHealthy® plans to its policyholders. These plans provide clients with more ways to take advantage of health and wellness benefits as well as vision benefits.

About Oxford Life
Oxford Life Insurance Company was founded in the Grand Canyon state of Arizona in 1965 and remains committed to supporting the senior market through life insurance, annuity, and Medicare supplement products that meet their financial needs. Oxford Life is continually working to support its mission of enabling seniors to live with dignity in their retirement years through financial security. Oxford Life is a strong player in every field where it competes, and constantly strives to be a leader in all categories of the life insurance and annuity markets. Oxford Life is a member of AMERCO®, a publicly traded financial holding network.

Contact: 
Mike Quaranta
Vice President, Sales
Oxford Life Insurance Co.
[email protected]

SOURCE Oxford Life Insurance Company


These press releases may also interest you

at 02:05
AstraZeneca: Revenue and EPS summary     Q1 2024 % Change $m Actual CER1 - Product Sales 12,177 15 18 - Alliance Revenue   457 59 59...

at 02:00
Indivior PLC (LSE/Nasdaq: INDV) today announced its financial results for the period ending March 31, 2024. The earnings release, investor presentation and webcast are available at www.indivior.com. The earnings release can be found at...

at 02:00
In response to the increasing complexities of the aging journey and the rising trend of...

at 02:00
PRISM BioLab, Co. Ltd. ("PRISM"), a leading discovery and development biotechnology company designing small molecule inhibitors of protein-protein interaction (PPI) targets, today announced that it has entered into a target-exclusive research and...

at 02:00
Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood...

at 01:24
Sedana Medical AB (publ) announces that all 235 randomized patients have been recruited for its INSPiRE-ICU 1 phase III clinical trial in the United States. Concurrently, the identical INSPiRE-ICU 2 trial is nearing completion, with 23 of 235...



News published on and distributed by: